Genmab to Participate in a Fireside Chat at the Citi Global Healthcare Conference in Miami

Core Points - Genmab A/S announced that its Chief Financial Officer, Anthony Pagano, will participate in a fireside chat at the Citi Global Healthcare Conference on December 4, 2025 [1] - A webcast of the event will be available on Genmab's website [1] Company Overview - Genmab is an international biotechnology company focused on improving patient lives through innovative antibody therapeutics [2] - The company has over 25 years of experience in developing next-generation antibody technology platforms, including bispecific T-cell engagers and antibody-drug conjugates [2] - Genmab aims to transform the lives of patients with cancer and serious diseases by 2030 with its proprietary antibody medicines [2] Company History and Presence - Established in 1999, Genmab is headquartered in Copenhagen, Denmark, with a presence in North America, Europe, and Asia Pacific [3]